Isaeva, A,
Averyanov, S,
Iskhakov, I,
Galimov, S,
Galimova, E,
Kiniabaev, T (2021) diseases, as well as for finding the safest and most effective
drugs with different mechanisms of action
approach in the development of new geroprotective
drugs. It was suggested that peculiarities
Bogdanov, A.V.,
Andreeva, O.V.,
Belenok, M.G.,
Voloshina, A.D.,
Enikeeva, K.I.,
Samorodov, A.V.,
Mironov, V.F. (2021) and have a significant antiaggregatory and anticoagulant activity at the level of reference
drugs